Showing results (411-420 of 1,290) with videos related to
Sort By:
Pageof 129
International Journal of Molecular Sciences|August 29, 2024
Master Regulators of Causal Networks in Intestinal- and Diffuse-Type Gastric Cancer and the Relation to the RNA Virus Infection PathwayShihori Tanabe, Sabina Quader, Horacio Cabral, et al.The Journal of Surgical Research|January 25, 2000
Outcomes after abdominal aortic aneurysm repair: comparison of mortality defined by centralized VA Patient Treatment File data versus hospital-based chart reviewA Kazmers, D Striplin, L A Jacobs, et al.The Journal of Hygiene|April 1, 1975
Response to influenza vaccine in adjuvant 65-4J W Smith, W B Fletcher, M Peters, et al.Preventive Medicine|February 13, 2001
Effect of a community action program on adult quit smoking rates in rural australian towns: the CART projectL Hancock, R Sanson-Fisher, J Perkins, et al.Preventive Medicine|April 17, 2001
The effect of a community action intervention on adolescent smoking rates in rural australian towns: the CART project. Cancer Action in Rural TownsL Hancock, R Sanson-Fisher, J Perkins, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|August 16, 2001
Calcium sensitization produced by G protein activation in airway smooth muscleH Yoshimura, K A Jones, W J Perkins, et al.Advances in Experimental Medicine and Biology|March 25, 2011
Predictive minimum description length principle approach to inferring gene regulatory networksVijender Chaitankar, Chaoyang Zhang, Preetam Ghosh, et al.Plos One|January 5, 2012
Mycobacterium abscessus glycopeptidolipid prevents respiratory epithelial TLR2 signaling as measured by HβD2 gene expression and IL-8 releaseLisa B Davidson, Rachid Nessar, Prakasha Kempaiah, et al.Journal of Molecular Biology|March 6, 2012
Solution structure of TT30, a novel complement therapeutic agent, provides insight into its joint binding to complement C3b and C3dKeying Li, Jayesh Gor, V Michael Holers, et al.Arthritis and Rheumatism|December 31, 1998
Reduction of NOS2 overexpression in rheumatoid arthritis patients treated with anti-tumor necrosis factor alpha monoclonal antibody (cA2)D J Perkins, E W St Clair, M A Misukonis, et al.Pageof 129